Trial Applying Policy to Eliminate or Reduce Inappropriate Narcotics in the General-population
CompletedNot applicableNCT03400384
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
To assess the effectiveness of a government-led population-based opioid intervention on discontinuation of opioid medication in community-dwelling adults with chronic non-cancer pain.
Study details
- Official title
- Using Policy to Reduce Opioids by Educating and Empowering Patients With Chronic Non-cancer Pain: The TAPERING Randomised Trial.
- Conditions
- Inappropriate Dose of Drug Administered
- Pain, Chronic
- Health Behavior
- Interventions
- Other: Direct-to-consumer educational brochure
- Sponsor
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Collaborators
- Canadian Institutes of Health Research (CIHR)
- Start date
- 2018-07-17
- Primary completion
- 2019-04-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults registered to receive pharmaceutical benefits in Manitoba, who are aged 18 years and over and who have received ≥90 days supply of opioids in the 6 months prior to the trial will be included. This will ensure chronic use and episodic use of opioids will be included. Exclusion Criteria: * People receiving palliative care, people with cancer, and people who receive opioids in hospital. People with dementia (identified by having received a prescription for memantine or a cholinersterase inhibitor in the previous 12 months) will be excluded.
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03400384